You have 9 free searches left this month | for more free features.

SGLTi

Showing 1 - 5 of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Nephropathy, Diabetic Nephropathies, Diabetes, Type 1 Trial in Herlev (Sotagliflozin, Placebo)

Not yet recruiting
  • Nephropathy
  • +6 more
  • Herlev, Denmark
    Steno Diabetes Center Copenhagen
Nov 19, 2023

Type2 Diabetes, Heart Failure With Reduced Ejection Fraction Trial in Hong Kong (Dapagliflozin)

Active, not recruiting
  • Type2 Diabetes
  • Heart Failure With Reduced Ejection Fraction
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Aug 2, 2021

Type 1 Diabetes Trial (Sotagliflozin, Volagidemab)

Not yet recruiting
  • Type 1 Diabetes
  • (no location specified)
Jan 20, 2023

Heart Failure, Diastolic, Diabetes, Type 2 Trial in Cleveland (Ertugliflozin 5 mg, Placebo oral tablet)

Recruiting
  • Heart Failure, Diastolic
  • Diabetes Mellitus, Type 2
  • Ertugliflozin 5 mg
  • Placebo oral tablet
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Dec 10, 2021

Heart Failure With Preserved Ejection Fraction, Diabete Type 2 Trial in Cairo (Metformin)

Not yet recruiting
  • Heart Failure With Preserved Ejection Fraction
  • Diabete Type 2
  • Cairo, Egypt
    clinical research uint- El-sheikh zayed specialized hospital SMC
Oct 8, 2023